Aller au contenuAller au menuAller à la recherche

SyDAD, Marie Curie Actions

Le 3 juillet 2015


Here download the file SyDAD info


 -      SyDAD is a European Training Network, sponsored by Horizon 2020 Marie Sklodowska Curie Actions that will support 15 Early Stage Researchers (ESRs, PhD students)
-       SyDAD is an interdiciplinary PhD programme including an innovative research programme with cutting edge methodology, an excellent training programme, international exchanges and a translational and collaborative orientation.
-       The aims of SyDAD are:

  1. To train 15 Early Stage Researchers  to a new generation of researchers with an innovative mindset and full understanding of the requirements of academia, pharmaceutical companies, the clinics and the societal challenges.
  2. To, through a collaborative research programme, elucidate how the different pathways underlying synaptic dysfunction in Alzheimer Disease relate to each other and to identify novel pharmaceutical targets and to elaborate a drug discovery platform for future implementation of the results.
    -       SyDAD will recruit 15 ESRs. Recruitment will start in September 2015 and be advertised on EURAXESS http://ec.europa.eu/euraxess/ . Indicative start date is January-April 2016.
    -       For eligibility rules see page 4 of this document.
    -       Participating organisations are Karolinska Institutet, Stockholm; University of Bordeaux, University of Milano; DZNE, Bonn; Janssen Pharmaceuticals, Beerse and Axon Neuroscience, Bratislava.
    -       Collaborations, secondments and training will also take place at Gothenburg University; Astra Zeneca Translational Center and AlzeCure Discovery, Serendipity Innovations and Alzheimer Europe.
    -       Further information of the programme is given on the next pages or by the respective site-responsible scientists:
    Karolinska Institutet, Stockholm: susanne.frykman @ ki.se (project manager)
    University of Bordeaux: christophe.mulle@u-bordeaux.fr
    University of Milano: monica.diluca@unimi.it
    DZNE, Bonn: eckhard.mandelkow@dzne.de
    Janssen Pharmaceuticals, Beerse: AEBNETH@its.jnj.com
    Axon Neuroscience, Bratislava: novak @ axon-neuroscience.eu

 

 

For further information, please contact / susanne.frykman@ki.se
Dernière mise à jour le 03.07.2015